Adamis Pharmaceuticals reported $8.15M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Adma Biologics ADMA:US USD 18.97M 24.11M
Brainstorm Cell Therapeutics BCLI:US USD 6.84M 750K
Cara Therapeutics CARA:US USD 34.66M 7.18M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Glaxosmithkline GSK:US GBP 6.64B 790M
Merk MRK:US USD 10.97B 1.31B
Pfizer PFE:US USD 13.23B 2.41B